UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies
Summary
AstraZeneca and GSK, the U.K.'s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday.
Description
AstraZeneca and GSK, the U.K.'s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source